I

ICU Medical
D

ICUI

143.960
USD
3.89
(2.78%)
مفتوح الان
حجم التداول
12,388
الربح لكل سهم
7
العائد الربحي
-
P/E
-30
حجم السوق
3,529,755,240
أصول ذات صلة
ABT
ABT
0.540
(0.41%)
132.210 USD
BAX
BAX
-2.060
(-6.13%)
31.570 USD
BDX
BDX
-5.745
(-2.54%)
220.650 USD
BMY
BMY
-0.450
(-0.76%)
59.130 USD
COO
COO
-2.040
(-2.51%)
79.170 USD
EW
EW
-0.310
(-0.43%)
71.730 USD
ISRG
ISRG
-7.78
(-1.53%)
500.54 USD
MDT
MDT
-0.710
(-0.80%)
88.260 USD
SYK
SYK
-13.51
(-3.58%)
364.35 USD
T
TFX
-1.240
(-0.88%)
140.050 USD
ZBH
ZBH
-0.210
(-0.19%)
112.270 USD
المزيد
الأخبار المقالات

العنوان: ICU Medical

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems(28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.